ALNY
Price
$303.77
Change
-$2.32 (-0.76%)
Updated
Jun 3 closing price
Capitalization
39.61B
57 days until earnings call
LQDA
Price
$16.53
Change
-$0.34 (-2.02%)
Updated
Jun 3 closing price
Capitalization
1.41B
64 days until earnings call
Interact to see
Advertisement

ALNY vs LQDA

Header iconALNY vs LQDA Comparison
Open Charts ALNY vs LQDABanner chart's image
Alnylam Pharmaceuticals
Price$303.77
Change-$2.32 (-0.76%)
Volume$965.35K
Capitalization39.61B
Liquidia
Price$16.53
Change-$0.34 (-2.02%)
Volume$2.39M
Capitalization1.41B
ALNY vs LQDA Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. LQDA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and LQDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ALNY: $303.77 vs. LQDA: $16.53)
Brand notoriety: ALNY and LQDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 94% vs. LQDA: 140%
Market capitalization -- ALNY: $39.61B vs. LQDA: $1.41B
ALNY [@Biotechnology] is valued at $39.61B. LQDA’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileLQDA’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • LQDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALNY and LQDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 6 TA indicator(s) are bullish while LQDA’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 6 bullish, 4 bearish.
  • LQDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than LQDA.

Price Growth

ALNY (@Biotechnology) experienced а +4.71% price change this week, while LQDA (@Biotechnology) price change was +5.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

LQDA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($39.6B) has a higher market cap than LQDA($1.41B). LQDA YTD gains are higher at: 40.561 vs. ALNY (29.094). LQDA has higher annual earnings (EBITDA): -122.53M vs. ALNY (-152.58M). ALNY has more cash in the bank: 2.63B vs. LQDA (170M). LQDA has less debt than ALNY: LQDA (148M) vs ALNY (1.3B). ALNY has higher revenues than LQDA: ALNY (2.35B) vs LQDA (14.1M).
ALNYLQDAALNY / LQDA
Capitalization39.6B1.41B2,803%
EBITDA-152.58M-122.53M125%
Gain YTD29.09440.56172%
P/E RatioN/AN/A-
Revenue2.35B14.1M16,652%
Total Cash2.63B170M1,548%
Total Debt1.3B148M880%
FUNDAMENTALS RATINGS
ALNY vs LQDA: Fundamental Ratings
ALNY
LQDA
OUTLOOK RATING
1..100
2069
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
2434
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3845
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LQDA's Valuation (82) in the Pharmaceuticals Major industry is in the same range as ALNY (99) in the Biotechnology industry. This means that LQDA’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (24) in the Biotechnology industry is in the same range as LQDA (34) in the Pharmaceuticals Major industry. This means that ALNY’s stock grew similarly to LQDA’s over the last 12 months.

ALNY's SMR Rating (100) in the Biotechnology industry is in the same range as LQDA (100) in the Pharmaceuticals Major industry. This means that ALNY’s stock grew similarly to LQDA’s over the last 12 months.

ALNY's Price Growth Rating (38) in the Biotechnology industry is in the same range as LQDA (45) in the Pharmaceuticals Major industry. This means that ALNY’s stock grew similarly to LQDA’s over the last 12 months.

ALNY's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LQDA (100) in the Pharmaceuticals Major industry. This means that ALNY’s stock grew similarly to LQDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYLQDA
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 26 days ago
67%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GHTMX15.07N/A
N/A
Goldman Sachs International T/M Eq Instl
AHSCX11.33N/A
N/A
Alger Health Sciences C
AUUIX22.19N/A
N/A
AB Select US Equity I
YAFIX19.42N/A
N/A
AMG Yacktman Focused I
WCMIX26.30N/A
N/A
WCM Focused International Growth Instl

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.76%
IONS - ALNY
53%
Loosely correlated
+1.91%
ARGX - ALNY
45%
Loosely correlated
-1.37%
SGMO - ALNY
42%
Loosely correlated
+5.77%
VXRT - ALNY
40%
Loosely correlated
-7.38%
ALXO - ALNY
39%
Loosely correlated
-0.72%
More

LQDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with ALNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
-2.02%
ALNY - LQDA
37%
Loosely correlated
-0.76%
AXON - LQDA
32%
Poorly correlated
+0.07%
AVXL - LQDA
30%
Poorly correlated
+3.70%
XERS - LQDA
29%
Poorly correlated
-7.92%
KURA - LQDA
29%
Poorly correlated
+1.90%
More